SNX14

protein-coding

sorting nexin 14, the group of Sorting nexins

Gene summary

This gene encodes a member of the sorting nexin family. Members of this family have a phox (PX) phosphoinositide binding domain and are involved in intracellular trafficking. The encoded protein also contains a regulator of G protein signaling (RGS) domain. Regulator of G protein signaling family members are regulatory molecules that act as GTPase activating proteins for G alpha subunits of heterotrimeric G proteins. Alternate splicing results in transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2014]

MANE transcript

NM_153816.6

Inheritance

AR

ClinVar variants

P:51U:173B:54

Top phenotype

Spinocerebellar ataxia, autosomal recessive 20

gnomAD constraint

pLI —, LoF o/e 0.62

Max pathogenic AF

—

Genomic locus

chr6:85,504,776-85,594,156

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~89.4 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

autosomal recessive spinocerebellar ataxia 20STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0014601

Submitter: Labcorp Genetics (formerly Invitae)

autosomal recessive spinocerebellar ataxia 20DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0014601

Submitter: ClinGen

Sorting nexin 14 (*SNX14*) was first reported in relation to autosomal recessive spinocerebellar ataxia 20 (SCAR20) in 2014 (Thomas et al., PMID: 25439728). SCAR20 is a pediatric onset disease which often involves ataxia, cerebellar atrophy, coarse facial features and intellectual disability (PMIDs 25439728, 25848753). Six variants (two stop-gain, one frame shift, one missense, one canonical splice, and one deep intronic) that have been reported in six probands in four publications (PMIDs: 25439728, 25848753, 27913285, 37485342) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence has been reached. The mechanism of pathogenicity is known to be loss of function. This gene-disease relationship is also supported by animal models, cell culture models, and biochemical data (PMIDs 33310904, 38625743, 29635513). The effects from a loss of function or expression was shown to be more pronounced in cerebral tissue and that disruption to lipid homeostasis is likely involved in pathogenesis. In summary, there is definitive evidence supporting the relationship between *SNX14* and autosomal recessive spinocerebellar ataxia 20. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Cerebellar Ataxia GCEP on the meeting date October 9, 2024 (SOP Version 11).

autosomal recessive spinocerebellar ataxia 20STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0014601

Submitter: Ambry Genetics

autosomal recessive spinocerebellar ataxia 20SUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0014601

Submitter: Orphanet

autosomal recessive spinocerebellar ataxia 20STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0014601

Submitter: PanelApp Australia

autosomal recessive spinocerebellar ataxia 20DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0014601

Submitter: G2P

Clinical Genomic Database (CGD)

Spinocerebellar ataxia, autosomal recessive 20AR

Manifestation: Craniofacial; Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 24501761; 25439728; 25848753Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to SNX14 variants in ClinVar

12 Conditions Cataloged
not providedTotal: 223
Inborn genetic diseasesTotal: 109
Autosomal recessive spinocerebellar ataxia 20Total: 53
SNX14-related disorderTotal: 22
not specifiedTotal: 21
Neurodevelopmental disorderTotal: 2
Cerebellar ataxiaTotal: 1
Spinocerebellar atrophyTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_153816.6. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
46
clinvar
2
clinvar
51
missense
1
clinvar
158
clinvar
5
clinvar
1
clinvar
165
nonsense
4
clinvar
12
clinvar
16
start loss
0
frameshift
8
clinvar
9
clinvar
17
splice donor/acceptor (+/-2bp)
4
clinvar
13
clinvar
12
clinvar
29
Total1734173513278

Highest pathogenic variant AF is 0.000047786907

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 228 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_153816.6RefSeqNP_722523.129MANE Select
ENST00000314673.8EnsemblENSP00000313121.329MANE Select
NM_001297614.3RefSeqNP_001284543.128Standard
NM_001304479.2RefSeqNP_001291408.128Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
snx14Danio rerio

Structure: neuron

Quality: apoptotic

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Biological Process

  • protein transport
  • autophagosome maturation

Molecular Function

  • phosphatidylinositol-3,5-bisphosphate binding

Cellular Component

  • lysosome
  • lysosomal membrane
  • late endosome
  • integral component of membrane
  • dendrite

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000314673
Coding exons
29
Length
88661
Individuals with no LoFs
125650
Homozygous LoFs
0
Heterozygous LoFs
98
Defined
125748
p
0.000390
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.853504620.7580.00002186215
Missense (PolyPhen)87141.320.615641963
Synonymous-0.7191691581.070.000007311692
Loss of Function2.613556.10.6240.00000270748

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000380.00037rare
Latino/Admixed American0.000150.00014rare
Ashkenazi Jewish0.0000990.000099rare
East Asian0.00120.0011notable
Finnish0.000140.00014rare
European (Non-Finnish)0.000440.00042rare
South Asian0.000400.00039rare
Other0.000340.00033rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Plays a role in maintaining normal neuronal excitability and synaptic transmission. May be involved in several stages of intracellular trafficking (By similarity). Required for autophagosome clearance, possibly by mediating the fusion of lysosomes with autophagosomes (Probable). Binds phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2), a key component of late endosomes/lysosomes (PubMed:25848753). Does not bind phosphatidylinositol 3-phosphate (PtdIns(3P)) (PubMed:25848753, PubMed:25148684). {ECO:0000250|UniProtKB:Q8BHY8, ECO:0000269|PubMed:25148684, ECO:0000269|PubMed:25848753, ECO:0000305|PubMed:25848753}.;

Recessive Scores

pRec
0.108

Intolerance Scores

LoFtool
0.964
RVIS EVS
-0.49
RVIS percentile EVS
22.65

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.508

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.